1. Shi, Jianli, Zhao, Ying, Vonderfecht, Tyson, Winey, Mark, Klymkowsky, Michael W. 2015. Centrin-2 (Cetn2) mediated regulation of FGF/FGFR gene expression in Xenopus. In Scientific reports, 5, 10283. doi:10.1038/srep10283. https://pubmed.ncbi.nlm.nih.gov/26014913/
2. Son, Ju A, Ahn, Hye Ri, You, Donglim, Eun, Jung Woo, Cheong, Jae Youn. 2022. Novel Gene Signatures as Prognostic Biomarkers for Predicting the Recurrence of Hepatocellular Carcinoma. In Cancers, 14, . doi:10.3390/cancers14040865. https://pubmed.ncbi.nlm.nih.gov/35205612/
3. Qiu, Pei-Yuan, Deng, Xi-Han, Li, Li. 2022. High expression of CETN2 is associated with platinum resistance and poor prognosis in epithelial ovarian cancer. In Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 25, 1340-1352. doi:10.1007/s12094-022-03031-2. https://pubmed.ncbi.nlm.nih.gov/36527574/
4. Ying, Guoxin, Avasthi, Prachee, Irwin, Mavis, Lucero, Mary T, Baehr, Wolfgang. . Centrin 2 is required for mouse olfactory ciliary trafficking and development of ependymal cilia planar polarity. In The Journal of neuroscience : the official journal of the Society for Neuroscience, 34, 6377-88. doi:10.1523/JNEUROSCI.0067-14.2014. https://pubmed.ncbi.nlm.nih.gov/24790208/
5. Kim, John J, Rajagopalan, Krithika, Hussain, Basil, Kulkarni, Prakash, Mooney, Steven M. 2013. CETN1 is a cancer testis antigen with expression in prostate and pancreatic cancers. In Biomarker research, 1, 22. doi:10.1186/2050-7771-1-22. https://pubmed.ncbi.nlm.nih.gov/24252580/
6. Etchegaray, Jean-Pierre, Mostoslavsky, Raul. . eNERgizing pluripotent gene transcription. In Cell stem cell, 9, 285-6. doi:10.1016/j.stem.2011.09.004. https://pubmed.ncbi.nlm.nih.gov/21982224/
智鼠故事 
